📼 Watch our Q1 2026 Quarterly Briefing Video.
Policy Panel, Las Vegas
Borealis, Stockholm
New Orleans BioInnovation Center
The REAL Summit, London
European Parliament, Brussels
Horizons, NYC
Psychedelics Symposium, Madison
Media & Consultancy
Psychedelic Alpha is an independent media, research, and advisory organisation focused on the development, regulation, and delivery of psychedelic medicines. Founded in 2020 by Josh Hardman, we are known for rigorous, data-driven coverage of drug development, policy, and access.
Alongside our more editorial work, we engage selectively with organisations seeking to understand the field, remain closely informed, and gain perspective on complex or emerging challenges. To that end, we have worked with investors, philanthropists, government agencies, startups, and large firms over the past half-decade. All engagements are led by Josh, who has authored hundreds of analyses on the psychedelic medicines field, spoken at conferences internationally, and contributed as an expert to government reports and advisory processes.
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
By signing up, you agree to our privacy policy. You can unsubscribe at any time.
Aside from group pricing, we also offer bespoke reports and regular briefings. Get in touch to discuss.